Form 4: DocGo Director Michael Burdiek Boosts Stake with Significant Stock Purchase

DocGo Inc. Director Michael J. Burdiek has acquired 10,000 shares of common stock at $1.33 per share, increasing his direct beneficial ownership to 641,560 shares.

Summary

• Michael J. Burdiek, a Director of DocGo Inc. (DCGO), reported a transaction on May 23, 2025.
• The transaction involved the acquisition of 10,000 shares of DocGo's common stock.
• The shares were purchased at a price of $1.33 per share.
• Following this transaction, Director Burdiek's direct beneficial ownership of DocGo common stock stands at 641,560 shares.
• This total beneficial ownership includes 34,965 restricted stock units (RSUs) granted under the Issuer's 2021 Stock Incentive Plan, which are scheduled to vest on December 13, 2025.

Sentiment

Score: 8

Explanation: The director's purchase of company stock signals strong confidence in the company's future prospects and valuation, which is a positive indicator for investors.

Positives

• DocGo Director Michael J. Burdiek purchased 10,000 shares of common stock, indicating confidence in the company's future prospects and valuation.
• The acquisition increases Director Burdiek's direct beneficial ownership to 641,560 shares, further aligning his interests with those of the company's shareholders.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future outlook beyond the vesting schedule of restricted stock units.

Industry Context

This document is an insider transaction report (Form 4) and does not provide information related to broader industry trends or competitive landscape. It solely details a director's personal stock acquisition.

Related Party Transactions

• Director Michael J. Burdiek acquired 10,000 shares of DocGo Inc. common stock at $1.33 per share, which is a related party transaction as it involves an insider.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal of confidence in the company's future, potentially influencing investor sentiment.

Next Steps

• Vesting of 34,965 restricted stock units (RSUs) on December 13, 2025, subject to the terms of the Issuer's 2021 Stock Incentive Plan.

Key Dates

Recommendation

Keywords

DocGo, DCGO, Form 4, insider trading, stock purchase, director, beneficial ownership, common stock, SEC filing, restricted stock units